Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Rev Sci Instrum ; 94(8)2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-38065133

RESUMEN

To determine the bidirectional transmittance distribution function (BTDF) of diffusely transmitting materials, two new primary facilities have been developed at the Physikalisch-Technische Bundesanstalt (PTB) and Aalto University (Aalto). A detailed description of both facilities and the different approaches used are presented in this paper. The performance of both facilities is compared by determining the BTDF of two different diffuser types in both in-plane and out-of-plane bidirectional geometries at four different wavelengths in the visible spectral range. Due to delayed completion of PTB's primary facility, the measured BTDF values are compared between Aalto's primary facility and another PTB setup, whose measurement scales are successfully transferred to PTB's primary facility by an internal comparison. A thorough analysis of the measurement uncertainty is presented, leading to a combined k = 1 standard uncertainty of 0.8%-1.2% for PTB's primary facility and 1.3%-1.7% for Aalto's primary facility. The BTDF results obtained agree well within their expanded k = 2 uncertainty. This indirect bilateral comparison shows that Aalto's and PTB's new facilities are suited as primary reference setups for the determination of the BTDF. These studies also reveal action points to improved measurement capabilities and for a reduction of the measurement uncertainty, depending on the type of diffuser under test.

2.
Appl Opt ; 62(13): 3320-3329, 2023 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-37132832

RESUMEN

In recent years, there has been a growing interest in the measurements of the bidirectional reflectance distribution function (BRDF) in industry and research and development. However, there is currently no dedicated key comparison to demonstrate the scale conformity. To date, scale conformity has been proved only for classical in-plane geometries, in comparisons between different national metrology institutes (NMIs) and designated institutes (DIs). This study aims at expanding that with nonclassical geometries, including, for the first time, to the best of our knowledge, two out-of-plane geometries. A total of four NMIs and two DIs participated in a scale comparison of the BRDF measurements of three achromatic samples at 550 nm in five measurement geometries. The realization of the scale of BRDF is a well-understood procedure, as explained in this paper, but the comparison of the measured values presents slight inconsistencies in some geometries, most likely due to the underestimation of measurement uncertainties. This underestimation was revealed and indirectly quantified using the Mandel-Paule method, which provides the interlaboratory uncertainty. The results from the presented comparison allow the present state of the BRDF scale realization to be evaluated, not only for classical in-plane geometries, but also for out-of-plane geometries.

3.
Opt Express ; 29(5): 7589-7600, 2021 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-33726257

RESUMEN

Large effect pigments, widely used in various fields of industrial applications, produce characteristic visual textures known as sparkle and graininess, which need to be quantified by objective or subjective methods. The development of preliminary measurement scales for sparkle and graininess, whose recommendation is now under discussion in the International Commission on Illumination (CIE), is described in this article. These scales are absolute, linear and traceable to standards of optical radiation metrology. The main purpose of this article is to justify the convenience of adopting these preliminary measurements scales, showing clear evidence that they correlate well with subjective evaluations. Before standardization, these scales need to be validated with more experimental data, including different specimens and experimental systems from other research groups.

4.
Opt Express ; 29(1): 219-231, 2021 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-33362110

RESUMEN

The bidirectional reflectance distribution function (BRDF) and the bidirectional scattering - surface reflectance distribution function (BSSRDF), which relate radiance at the surface to irradiance and radiant flux, respectively, are regarded as the most fundamental scattering quantities used to determine the reflectance of objects. However, for materials where the optical radiation is transmitted under the surface, this radiance depends not only on irradiance and radiant flux, but also on the size of the irradiated area of the surface. This article provides insight into such dependence under the special condition in which the radiance is evaluated within the irradiated area and, consequently, is produced by both the insurface reflection and the subsurface scattering, in contrast to the situation in which the radiance is evaluated at non-irradiated areas and only subsurface scattering contributes. By explicitly considering both contributions, two other scattering quantities are defined: one that accounts exclusively for the insurface reflection and the other that accounts for subsurface scattering. In this regard, these quantities might be considered more fundamental than the BRDF and the BSSRDF, although they are coincident with these two functions apart from the above-mentioned special condition and for materials with negligible subsurface scattering. In this work, the relevance of the proposed scattering quantities is supported by experimental data, practical considerations are given for measuring them, and their relation to the bidirectional transmittance distribution function (BTDF) is discussed.

5.
Appl Opt ; 56(7): 1996-2006, 2017 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-28248401

RESUMEN

The field of spectral radiance factor (SRF) measurements has seen growing interest in recent years. Scale conformity has so far only been established between the national metrology institutes (NMIs) of Germany and the USA. This study aims at a bigger, multilateral scale comparison. For this purpose, a total of six NMIs participated in a scale comparison of goniospectrophotometers based on neutral and colored diffusely reflecting ceramics samples. In addition, two universities, providing a home-built gonioreflectometer and two widely used commercially available color measurement instruments, respectively, were involved. The wavelength range of the scale comparison covers the visible wavelength range from 380 nm to 780 nm. Results indicate systematic issues and that the uncertainty evaluation of the NMIs requires further work; although for the greatest part of the covered spectral range the agreement is good.

6.
Nervenarzt ; 84(2): 157-65, 2013 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-23325310

RESUMEN

Hereditary neuropathies belong to the most common neurogenetic disorders. They appear mostly as sensory and motor neuropathies but there are also pure sensory, pure motor as well as sensory and autonomic hereditary neuropathies. In clinical practice, knowledge of hereditary neuropathies is important in order to recognize them among polyneuropathies and achieve a successful genetic diagnosis. The molecular genetics of hereditary neuropathies are very heterogeneous with currently more than 40 known disease-causing genes. The 4 most common genes account for almost 90% of the genetically diagnosed hereditary neuropathies. In this review article we provide an overview of the currently known genes and propose a rational genetic work-up protocol of the most common genes.


Asunto(s)
Enfermedades del Sistema Nervioso/genética , Algoritmos , Enfermedad de Charcot-Marie-Tooth/clasificación , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/epidemiología , Enfermedad de Charcot-Marie-Tooth/genética , Estudios Transversales , Evaluación de la Discapacidad , Pruebas Genéticas , Neuropatías Hereditarias Sensoriales y Autónomas/clasificación , Neuropatía Hereditaria Motora y Sensorial/clasificación , Neuropatía Hereditaria Motora y Sensorial/diagnóstico , Neuropatía Hereditaria Motora y Sensorial/epidemiología , Neuropatía Hereditaria Motora y Sensorial/genética , Humanos , Enfermedades del Sistema Nervioso/clasificación , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/epidemiología , Examen Neurológico , Polineuropatías/clasificación , Polineuropatías/diagnóstico , Polineuropatías/epidemiología , Polineuropatías/genética , Pronóstico
7.
Appl Opt ; 46(29): 7337-44, 2007 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-17932548

RESUMEN

The spectral reflectance and responsivity of Ge- and InGaAs-photodiodes at (nearly) normal and oblique incidence (45 degrees) were investigated. The derived data allow a calculation of the photodiodes responsivities for any incident angle. The measurements were carried out with s- and p-polarized radiation in the wavelength range from 1260 to 1640 nm. The spectral reflectance of the photodiodes was modeled by using the matrix approach developed for thin-film optical assemblies. The comparison between the calculated and measured reflectance shows a difference of less than 2% for the Ge-photodiode. For the InGaAs-photodiode, the differences between measured and calculated reflectance are larger, i.e., up to 6% for wavelengths between 1380 and 1580 nm. Despite the larger differences between calculated and measured spectral reflectances for the InGaAs-photodiode, the difference between calculated and measured spectral responsivity is even smaller for the InGaAs-photodiode than for the Ge-photodiode, i.e., < or =1.2% for the InGaAs-photodiode compared to < or =2.2% for the Ge-photodiode. This is because the difference in responsivity is strongly correlated to the absolute spectral reflectance level, which is much lower for the InGaAs-photodiode. This observation also shows the importance of having small reflectances, i.e., appropriate antireflection coatings for the photodiodes. The relative standard uncertainty associated with the modeled spectral responsivity is about 2.2% for the Ge-photodiode and about 1.2% for the InGaAs-photodiode for any incident angle over the whole spectral range measured. The data obtained for the photodiodes allow the calculation of the spectral responsivity of Ge- and InGaAs-trap detectors and the comparison with experimental results.

8.
Cephalalgia ; 26(2): 158-61, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16426270

RESUMEN

Mutations in the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Exons 3 and 4 are mutation hotspots. Migraine is a clinical hallmark of CADASIL. The objective of this study was to investigate whether genetic variants in exons 3 and 4 of the NOTCH3 gene are associated with migraine. Exons 3 and 4 of the NOTCH3 were analysed for mutations and polymorphisms by direct DNA sequencing in 97 migraineurs and the same number of control individuals. No mutations in exons 3 and 4 of the NOTCH3 gene were found in 97 patients with migraine. However, association analysis revealed significant association of the single nucleotide polymorphism (SNP) rs1043994 with migraine.


Asunto(s)
Análisis Mutacional de ADN , Pruebas Genéticas/métodos , Trastornos Migrañosos/epidemiología , Trastornos Migrañosos/genética , Receptores Notch/genética , Adolescente , Adulto , Femenino , Predisposición Genética a la Enfermedad/epidemiología , Predisposición Genética a la Enfermedad/genética , Variación Genética , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Mutación , Polimorfismo Genético , Polimorfismo de Nucleótido Simple/genética , Prevalencia , Receptor Notch3 , Medición de Riesgo/métodos , Factores de Riesgo
9.
J Neural Transm Suppl ; (68): 147-56, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15354400

RESUMEN

Panic disorder like other neuropsychiatric disorders is believed to be caused by multiple psychosocial and biological factors. Several lines of evidence point to a role for the peptide neurotransmitter cholecystokinin in the pathogenesis of panic disorder. We therefore determined the allele and genotype frequencies of a single nucleotide polymorphism in the CCK gene (-36C>T) and one CT repeat polymorphism in the CCK-B-receptor gene in a German panic disorder sample (n = 115 for CCK gene polymorphism, n = 111 for CCK-B-receptor polymorphism) and compared them with gender and age matched controls. The length of the polymorphic CT repeat alleles varies between 146 bp and 180 bp. We first analysed the results by a permutation test which provided evidence for heterogeneity between patients and controls (p=0.002). We then analysed the data as a di-allelic polymorphism with a short (146-162bp) and a long (164-180bp) allele and as a tetra-allelic polymorphism with 4 alleles (146-154bp, 156-162bp, 164-170bp, 172-180bp). In the di-allelic analysis as well as in the tetra-allelic analysis there was an excess of the longer allele (p = 0.001) or the two longer alleles (p = 0.041) respectively in patients with panic disorder. No difference between groups was observed for the -36C > T polymorphism. Our findings are consistent with the notion that genetic variation in the CCK neurotransmitter system contributes to the pathogenesis of panic disorder.


Asunto(s)
Colecistoquinina/genética , Trastorno de Pánico/genética , Polimorfismo Genético/genética , Receptor de Colecistoquinina B/genética , Adulto , Intervalos de Confianza , Femenino , Frecuencia de los Genes/genética , Variación Genética/genética , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Receptor de Colecistoquinina B/fisiología
10.
Neurology ; 62(12): 2203-8, 2004 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-15210883

RESUMEN

OBJECTIVE: To describe the clinical and neuroradiologic features and chromosomal mapping of a novel autosomal dominant disease affecting the basal ganglia. METHODS: The authors characterized a large family with autosomal dominant basal ganglia disease (ADSD) clinically and by MRI, MR spectroscopy (MRS), and SPECT. The authors performed a whole genome genetic linkage scan to map the underlying genetic defect. RESULTS: The main clinical features of the disease are dysarthria and gait disturbance without any apparent reduction in life expectancy. MRI demonstrated a distinctive lesion pattern restricted mainly to the putamen and caudate nucleus. Genetic linkage analysis localized the causative genetic defect to a 3.25 megabase candidate region on chromosome 5q13.3-q14.1. CONCLUSIONS: ADSD is an autosomal dominant basal ganglia disease mapping to chromosome 5q13.3-q14.1.


Asunto(s)
Enfermedades de los Ganglios Basales/diagnóstico , Enfermedades de los Ganglios Basales/genética , Cromosomas Humanos Par 5 , Enfermedades de los Ganglios Basales/fisiopatología , Núcleo Caudado/patología , Mapeo Cromosómico , Análisis Mutacional de ADN , Disartria/etiología , Femenino , Ferritinas/genética , Marcha , Genes Dominantes , Ligamiento Genético , Humanos , Hipocinesia/etiología , Imagen por Resonancia Magnética , Masculino , Linaje , Putamen/patología , Tomografía Computarizada de Emisión de Fotón Único , Tomografía Computarizada por Rayos X
11.
Am J Med Genet B Neuropsychiatr Genet ; 117B(1): 70-8, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12555239

RESUMEN

Panic disorder is an anxiety disorder with an estimated heritability of 48%. Variation in the gene of the nuclear transcription factor "cAMP-responsive element modulator" (CREM) might contribute to its pathogenesis. CREM knock-out mice exhibit significantly less anxiety behavior than wild-type mice and the alternative CREM gene product "inducible cAMP early repressor" (ICER) plays a pivotal role in the hypothalamo-pituitary-adrenal (HPA) axis, which is disturbed in panic disorder. We characterized the genomic organization of the human CREM gene and performed a systematic mutation screening by means of single stranded conformational analysis (SSCA) in a sample of 40 German patients with panic disorder (DSM-III-R). Four novel single nucleotide polymorphisms in CREM promoters P 1 and P 4, one trinucleotide (ATT)-repeat polymorphism in CREM promoter P 2-generating the ICER isoform-and a rare amino acid substitution in CREM exon glut 2 were identified. Association analysis in an extended sample of German patients (n = 88) revealed a significant excess of the shorter CREM P 2 promoter eight-repeat trinucleotide allele and of genotypes containing the eight-repeat trinucleotide allele in panic disorder (P = 0.02), in particular in panic disorder without agoraphobia (P = 0.001). A replication study in independent Italian (n = 76) and Spanish (n = 62) samples, however, failed to confirm this observation. This suggests that the CREM P 2 promoter trinucleotide polymorphism is not a major susceptibility factor in the pathogenesis of panic disorder. Functional analysis of the observed CREM P 2 promoter polymorphism as well as studies in independent panic disorder samples are necessary.


Asunto(s)
Proteínas de Unión al ADN/genética , Trastorno de Pánico/genética , Polimorfismo Genético , Proteínas Represoras , Agorafobia/genética , Estudios de Casos y Controles , Modulador del Elemento de Respuesta al AMP Cíclico , Análisis Mutacional de ADN , Exones , Femenino , Frecuencia de los Genes , Genoma , Genotipo , Alemania , Humanos , Masculino , Trastorno de Pánico/epidemiología , Regiones Promotoras Genéticas , Factores Sexuales , Factores de Transcripción/genética
12.
Neurology ; 58(8): 1273-6, 2002 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-11971098

RESUMEN

Giant axonal neuropathy (GAN) is an autosomal recessive neurologic disorder clinically characterized by a severe polyneuropathy, CNS abnormalities, and characteristic tightly curled hair. Recently, mutations in the gigaxonin gene have been identified as the underlying genetic defect. The authors report two novel mutations confirming that GAN is caused by mutations in the gigaxonin gene and raise the question whether some mutations may cause a mild subclinical neuropathy.


Asunto(s)
Proteínas del Citoesqueleto/genética , Enfermedades del Sistema Nervioso Periférico/genética , Mutación Puntual/genética , Adolescente , Secuencia de Aminoácidos , Axones/patología , Análisis Mutacional de ADN , Electrofisiología , Humanos , Masculino , Datos de Secuencia Molecular , Linaje
13.
Bioelectromagnetics ; 21(5): 338-45, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10899769

RESUMEN

We report an investigation on the influence of high frequency electromagnetic fields (EMF) on the permeability of an in vitro model of the blood-brain barrier (BBB). Our model was a co-culture consisting of rat astrocytes and porcine brain capillary endothelial cells (BCEC). Samples were characterized morphologically by scanning electron microscopy and immunocytochemistry. The BBB phenotype of the BCEC was shown by the presence of zona occludens protein (ZO-1) as a marker for tight junctions and the close contact of the cells together with the absence of intercellular clefts. Permeability measurements using (14)C-sucrose indicated a physiological tightness which correlated with the morphological findings and verified the usefulness of our in vitro model. Samples were exposed to EMF conforming to the GSM1800-standard used in mobile telephones (1.8 GHz). The permeability of the samples was monitored over four days and compared with results of samples that were cultured identically but not exposed to EMF. Exposure to EMF increased permeability for (14)C-sucrose significantly compared to unexposed samples. The underlying pathophysiological mechanism remains to be investigated.


Asunto(s)
Barrera Hematoencefálica/fisiología , Campos Electromagnéticos/efectos adversos , Sacarosa/metabolismo , Animales , Astrocitos/citología , Astrocitos/metabolismo , Células Cultivadas , Técnicas de Cocultivo , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Microscopía Electrónica de Rastreo , Microondas/efectos adversos , Permeabilidad , Ratas , Sacarosa/sangre , Porcinos
15.
Eur J Nucl Med ; 26(10): 1274-8, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10541825

RESUMEN

3-[(123)I]Iodo-l-alpha-methyltyrosine ((123)I-IMT) is used for the diagnosis and monitoring of brain tumours by means of single-photon emission tomography (SPET). To date, little has been known about the system for the transport of (123)I-IMT into brain tumour cells. It is assumed that (123)I-IMT is transported by a specific carrier for large, neutral amino acids (L-system). In this study, rat C6 glioma cells were used to characterize the uptake system of (123)I-IMT and to investigate its precise kinetics. The time course of (123)I-IMT uptake into the cells was examined for a range of 1-60 min. (123)I-IMT uptake rates with varying concentrations of (123)I-IMT (2. 5-50 microM) in the medium were quantified to assess the kinetic parameters of (123)I-IMT transport. Furthermore, competition of (123)I-IMT with other amino acids was investigated to identify the distinct transport systems involved in (123)I-IMT uptake. (123)I-IMT uptake into C6 glioma cells was linear for approximately 10 min and reached a steady-state level within 30 min. The analysis of the rate of uptake of (123)I-IMT at different concentrations was concordant with the predominance of a single uptake system. The apparent Michaelis constant (K(m)) of (123)I-IMT was 26.2+/-1.9 microM, and the maximum transport velocity (V(max)) was 35.4+/-1.7 nmol/mg protein per 10 min. 77%+/-10% of (123)I-IMT transport was sodium independent and 23%+/-3% was sodium dependent. Competitive inhibition of (123)I-IMT uptake by 2-aminobicyclo[2.2. 1]heptane-2-carboxylic acid, alpha-(methylamino)isobutyric acid and naturally occurring amino acids revealed a major (123)I-IMT transport via the sodium-independent system L (72%) and a minor uptake via the sodium-dependent system B(0,+) (17%). Our results show that (123)I-IMT transport into C6 glioma cells is principally mediated by the L-system and to a minor extent by the B(0,+)-system. The kinetic parameters of (123)I-IMT uptake are in the range of those of naturally occurring amino acids.


Asunto(s)
Neoplasias Encefálicas/metabolismo , Glioma/metabolismo , Metiltirosinas/farmacocinética , Radiofármacos/farmacocinética , Animales , Transporte Biológico Activo , Indicadores y Reactivos , Ratas , Células Tumorales Cultivadas
17.
Genomics ; 62(2): 242-50, 1999 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-10610718

RESUMEN

Hereditary neuralgic amyotrophy (HNA) is an autosomal dominant recurrent neuropathy mapped to a 4-cM interval on chromosome 17q25 between the short tandem repeat (STR) markers D17S1603 and D17S802. Chromosome 17q25 in general and the 4-cM HNA region in particular are also implicated in the pathogenesis of a number of tumors (tylosis with esophageal cancer, sporadic breast and ovarian tumors) and harbor a psoriasis susceptibility locus. Initial attempts to construct a yeast artificial chromosome contig failed. Therefore, we have now constructed a complete P1 artificial chromosome (PAC) and bacterial artificial chromosome (BAC) contig of the region flanked by the STR markers D17S1603 and D17S802. The contig contains 22 PAC and 64 BAC clones and covers a physical distance of approximately 1. 5 Mb. A total of 83 sequence-tagged site (STS) markers (10 known STSs and STRs, 56 STSs generated from clone end-fragments, 12 expressed sequence tags, and 5 known genes) were mapped on the contig, resulting in an extremely dense physical map with approximately 1 STS per 20 kb. This sequence-ready PAC and BAC contig will be pivotal for the positional cloning of the HNA gene as well as other disease genes mapping to this region.


Asunto(s)
Bacteriófago P1/genética , Cromosomas Bacterianos/genética , Cromosomas Humanos Par 17/genética , Genes , Transcripción Genética , Neuritis del Plexo Braquial/genética , Cromosomas Artificiales de Levadura/genética , Clonación Molecular , Mapeo Contig/métodos , Etiquetas de Secuencia Expresada , Humanos , Neoplasias/genética , Psoriasis/genética , Lugares Marcados de Secuencia
18.
Eur J Hum Genet ; 7(8): 920-7, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10602368

RESUMEN

Hereditary neuralgic amyotrophy (HNA) is an autosomal dominant, recurrent focal neuropathy. HNA is characterised by episodes of painful brachial plexus neuropathy with muscle weakness and atrophy, as well as sensory disturbances. Single episodes are commonly preceded by non-specific infections, immunisations or parturition. Mild dysmorphic features and short stature are present in some HNA families, but absolute co-segregation with HNA has not been described. To refine the previously described HNA locus on chromosome 17q25, we performed a genetic linkage study in five HNA families with different geographic origins. Significant linkage was obtained with chromosome 17q24-q25 short tandem repeat (STR) markers in three HNA families and suggestive linkage was found in the other two HNA families. Analysis of the informative recombinations in affected individuals allowed us to reduce the HNA linkage interval to a candidate region of 3.5 cM.


Asunto(s)
Neuritis del Plexo Braquial/genética , Cromosomas Humanos Par 17 , Bandeo Cromosómico , Femenino , Ligamiento Genético , Marcadores Genéticos , Humanos , Escala de Lod , Masculino , Linaje , Penetrancia
20.
Ann Hum Genet ; 62(Pt 5): 397-400, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10088036

RESUMEN

HNA is an autosomal dominant recurrent focal neuropathy involving the brachial plexus. The etiology of HNA is unknown but the genetic defect most likely affects a non-neuronal tissue. We previously described linkage to chromosome 17q24-q25 in two HNA-families. Here we report the mutation analysis of two candidate genes: a cDNA encoding a putative sialyltransferase and the SFRS2 splicing factor including the c-myb ET-locus which is encoded on the opposite strand of the SFRS2 gene. The complete protein coding regions of both genes were studied by direct DNA sequencing. We did not find a disease associated mutation indicating that these genes are most likely not involved in the pathogenesis of HNA. However, we identified and characterized a rare AvaII polymorphism in the SFRS2 gene and detected a sequencing error, leading to an amino acid change (Val11Leu) in the published sequence of the putative sialyltransferase.


Asunto(s)
Neuritis del Plexo Braquial/genética , Proteínas Nucleares/genética , Proteínas Proto-Oncogénicas/genética , Ribonucleoproteínas , Sialiltransferasas/genética , Transactivadores/genética , Análisis Mutacional de ADN , Femenino , Humanos , Masculino , Modelos Genéticos , Linaje , Polimorfismo Genético , Polimorfismo de Longitud del Fragmento de Restricción , Proteínas Proto-Oncogénicas c-myb , Factores de Empalme Serina-Arginina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA